![Daphne Middelaer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Daphne Middelaer is Manager of Clinical Operations for Xillix Technologies Corp.
She joined Xillix in 2002.
She has over 15 years of experience in the healthcare industry.
Anciens postes connus de Daphne Middelaer
Sociétés | Poste | Fin |
---|---|---|
Biomerge Industries Ltd.
![]() Biomerge Industries Ltd. Medical SpecialtiesHealth Technology Biomerge Industries Ltd. is a Canadian medical device company and leader in fluorescence endoscopy for improved cancer detection. The Company’s first-generation product, Xillix LIFE-Lung™ received Pre-Market Approval (PMA) from the U.S. FDA in 1996. Xillix’s latest device, Onco-LIFE™, incorporates fluorescence and white-light endoscopy in a single device that has been developed for the detection and localization of lung and gastrointestinal (GI) cancers. | Corporate Officer/Principal | 28/05/2009 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Biomerge Industries Ltd.
![]() Biomerge Industries Ltd. Medical SpecialtiesHealth Technology Biomerge Industries Ltd. is a Canadian medical device company and leader in fluorescence endoscopy for improved cancer detection. The Company’s first-generation product, Xillix LIFE-Lung™ received Pre-Market Approval (PMA) from the U.S. FDA in 1996. Xillix’s latest device, Onco-LIFE™, incorporates fluorescence and white-light endoscopy in a single device that has been developed for the detection and localization of lung and gastrointestinal (GI) cancers. | Health Technology |